Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 13.62 CNY 0.81% Market Closed
Market Cap: 5.7B CNY
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Novogene Co Ltd

Wall Street analysts forecast Novogene Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Novogene Co Ltd is 14.88 CNY with a low forecast of 13.84 CNY and a high forecast of 16.25 CNY.

Lowest Forecast
Wall Street Target
13.84 CNY
2% Upside
Average Forecast
Wall Street Target
14.88 CNY
9% Upside
Highest Forecast
Wall Street Target
16.25 CNY
19% Upside
Lowest
Price Target
13.84 CNY
2% Upside
Average
Price Target
14.88 CNY
9% Upside
Highest
Price Target
16.25 CNY
19% Upside
Novogene Co Ltd Competitors:
Price Targets
TKNO
Alpha Teknova Inc
88% Upside
MCAP
MedCap AB (publ)
27% Upside
MEDP
Medpace Holdings Inc
4% Upside
M
300463
Maccura Biotechnology Co Ltd
18% Upside
TKNO
Alpha Teknova Inc
88% Upside
MCAP
MedCap AB (publ)
27% Upside
MEDP
Medpace Holdings Inc
4% Upside
M
300463
Maccura Biotechnology Co Ltd
18% Upside
BIO
Bio Rad Laboratories Inc
49% Upside
AZTA
Azenta Inc
86% Upside
DHR
Danaher Corp
35% Upside
WST
West Pharmaceutical Services Inc
38% Upside

Revenue
Forecast

Revenue Estimate
Novogene Co Ltd

For the last 5 years the compound annual growth rate for Novogene Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 12%.

7%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Novogene Co Ltd

For the last 5 years the compound annual growth rate for Novogene Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 17%.

11%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Novogene Co Ltd

For the last 5 years the compound annual growth rate for Novogene Co Ltd's net income is 11%. The projected CAGR for the next 2 years is 27%.

11%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Novogene Co Ltd's stock price target?
Price Target
14.88 CNY

According to Wall Street analysts, the average 1-year price target for Novogene Co Ltd is 14.88 CNY with a low forecast of 13.84 CNY and a high forecast of 16.25 CNY.

What is Novogene Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 5 years the compound annual growth rate for Novogene Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 12%.

What is Novogene Co Ltd's Operating Income forecast?
Projected CAGR
17%

For the last 5 years the compound annual growth rate for Novogene Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 17%.

What is Novogene Co Ltd's Net Income forecast?
Projected CAGR
27%

For the last 5 years the compound annual growth rate for Novogene Co Ltd's net income is 11%. The projected CAGR for the next 2 years is 27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.